Inventor
Dennis Hurley
Inventor
San Marcos, CA, US
Overview
Patents· 29 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds32%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
A61KPreparations for medical, dental or toiletry purposes26%
C07BGeneral methods of organic chemistry4%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
C07CAcyclic or carbocyclic compounds2%
PatentTitleYear
10,647,661Carboxamides as modulators of sodium channels202010,233,191Fused piperidine amides as modulators of ion channels20199,630,956'Compounds useful as inhibitors of ATR kinase'20179,181,273'Morpholine-spirocyclic piperidine amides as modulators of ion channels'20158,999,976'Modulators of cystic fibrosis transmembrane conductance regulator'20158,884,018'Process for preparing modulators of cystic fibrosis transmembrane conductance regulator'20148,828,996'Morpholine-spirocyclic piperidine amides as modulators of ion channels'20148,802,700'Modulators of ATP-Binding Cassette transporters'20148,785,640'Modulators of cystic fibrosis transmembrane conductance regulator'20148,754,222'Process for preparing modulators of cystic fibrosis transmembrane conductance regulator'20148,633,189'Modulators of cystic fibrosis transmembrane conductance regulator'20148,614,327'Modulators of ATP-binding cassette transporters'20138,598,205'Modulators of cystic fibrosis transmembrane conductance regulator'20138,513,282'Modulators of cystic fibrosis transmembrane conductance regulator'20138,497,295'Spiroindoline modulators of muscarinic receptors'20138,410,112'Compounds useful as inhibitors of ATR kinase'20138,367,660'Modulators of cystic fibrosis transmembrane conductance regulator'20138,367,691'Modulators of muscarinic receptors'20138,344,147'Process for preparing modulators of cystic fibrosis transmembrane conductance regulator'20138,283,354'Quinazolines useful as modulators of ion channels'20128,263,605'Modulators of muscarinic receptors'20128,258,148'Spiroindoline modulators of muscarinic receptors'20127,928,107'Quinazolines useful as modulators of ion channels'20117,880,007'Bicyclic substituted phenyl piperidine modulators of muscarinic receptors'20117,863,449'Modulators of muscarinic receptors'20117,858,635'Spiro compounds as modulators of muscarinic receptors'20107,786,141'Dihydrospiroindene modulators of muscarinic receptors'20107,696,201'Modulators of muscarinic receptors'20107,465,738'Compounds useful as promoters of SMN2'2008Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2008–2020Patents assigned to VERTEX PHARMA (29)· patent assignee history
2008–2020Based in San Marcos, CA, US· patent location history
2012–2014Patents assigned to SILINA ALINA (9)· patent assignee history
2012–2014Patents assigned to SHETH URVI (5)· patent assignee history
2012–2013Patents assigned to BERGERON DANIELE M (4)· patent assignee history
2013–2017Patents assigned to HURLEY DENNIS JAMES (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| VERTEX PHARMA | 29 | 2008–2020 |
| SILINA ALINA | 9 | 2012–2014 |
| HURLEY DENNIS JAMESself | 5 | 2013–2017 |
| SHETH URVI | 5 | 2012–2014 |
| BERGERON DANIELE M | 4 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Marcos, California, US | 29 | 2008–2020 |